From: Mastic gum has no effect on Helicobacter pylori load in vivo

Slides:

Advertisements

Similar presentations

The H pylori Story – Helicobacter pylori through the ages

Advertisements

Update on Screening of Gastrointestinal Diseases Niraj Jani, M.D. Greater Baltimore Medical Center 1/30/15.

Efficacy of 5-Day Levofloxacin- Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection Your Logo Gastroenterology, Volume 143,

ESA Style Question. Mrs Cole, a 56 year old woman presents to her GP with a burning epigastric pain, for the previous two weeks. The pain is worse at.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

How to Critically Appraise A Diagnostic Article Sandy De Groote.

LOGO Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-lable, randomised trial 杨天 Epidemiology.

The Recurrence of Helicobacter pylori Infection: Incidence and Variables Inﬂuencing It. A Critical Review Ph.D. candidate: Tian-yi Wang Gisbert J P. The.

WEEK 1 You have 10 seconds to name…

Significant Figures. Significant Figures One sig fig One sig fig Two sig figs One sig fig One sig fig One sig fig four sig figs.

R3 정명화 /Prof. 장재영 Gastrointest. Endosc. 2012; 75:39-46.

Effects of omadacycline on gut microbiota populations and Clostridium difficile germination, proliferation and toxin production in an in vitro model of.

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based.

HELICOBACTER PYLORI Millions of years old microorganism of mankind Causes a spectrum of diseases Obviously requires high priority Treatment strategies.

PETER MALFERTHEINER, VIOLA SCHULTZE,BERND ROSENKRANZ, STEFAN H.E. KAUFMANN TIMO ULRICHS,DEBORAH NOVICKI,FRANCESCO NORELLI,MARIO CONTORNI GASTROENTEROLOGY.

Dyspepsia. one or more of the following symptoms Postprandial fullness, early satiation, epigastric pain, or burning.

R3 김재민 / Prof. 장영운 Journal conference 1.

Copyright © 1998 American Medical Association. All rights reserved.

Follow-up Testing After Treatment of Helicobacter Pylori Infections: Cautions, Caveats, and Recommendations Taraq A. Attumi, MD, David Y. Graham, MD

Labeled urea breath test to detect Helicobacter infection

Figure 1. Rate of antimicrobial resistance in S. pneumoniae

Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies? J.P. Gisbert,

Identification of optimal dose and dosing regimen of clofazimine for the treatment of multi-drug resistant tuberculosis (MDR-TB) based on pharmacokinetic.

Birol Şafak, M. D. , Özgür Baykan, M. D. , Osman Kılınç, M. D

Supplemental Digital Content 2

Figure 5. The cumulative calcium loss from the enamel specimens, when the specimens were treated daily for 3 min with 30% (w/v) slurries of the toothpastes.

SIBO: Clinical Strategies

Figure 6. RRs for clinical cure rates stratified by different diseases

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*,

Ten-day bismuth-containing quadruple therapy is effective as first-line therapy for Helicobacter pylori–related chronic gastritis: a prospective randomized.

Volume 144, Issue 3, Pages (March 2013)

Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,

by Toru Takahashi, Toshiaki Yujiri, and Yukio Tanizawa

Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans? A. Schumacher,

RAPID RELIABLE RESULTS

Anna Tinnert, Annika Hamlet, Ann-Mari Svennerholm

The role of internal urease in acid resistance of Helicobacter pylori

Grade one First term Second term Learning unit Learning unit

ACR20, ACR50, and ACR70 response rates during the 12-week study of Japanese patients with rheumatoid arthritis treated with baricitinib or placebo. ACR20,

Ten-day bismuth-containing quadruple therapy is effective as first-line therapy for Helicobacter pylori–related chronic gastritis: a prospective randomized.

Follow-up Testing After Treatment of Helicobacter Pylori Infections: Cautions, Caveats, and Recommendations Taraq A. Attumi, MD, David Y. Graham, MD

The normal gastric microflora and Helicobacter pylori; before, during and after treatment with omeprazole and amoxycillin Inger Adamsson, Charlotta Edlund,

Effectiveness of proton pump inhibitors in nonerosive reflux disease

Potential diagnostic utility of intermittent administration of short-acting gonadotropin- releasing hormone agonist in gonadotropin deficiency Carrie.

Significant Figures.

Helicobacter pylori associated with idiopathic thrombocytopenic purpura Masaya Mukai, MD, PhD, Yujiro Kon, MD, Atsushi Notoya, MD, PhD, Michifumi Kohno,

Anna Tinnert, Annika Hamlet, Ann-Mari Svennerholm

Figure 1. Ten chemotherapeutic drugs induce the bacterial SOS response

Figure 1 MOR103 sequential-dose trial flowchart of study population with multiple sclerosis aPatients received 2 doses of study drug before trial withdrawal.

Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans? A. Schumacher,

Supplemental Figure 1A Pt Pt Pre-treatment

Marina Rektorschek, David Weeks, George Sachs, Klaus Melchers

Laura K. Certain, Jeffrey C. Way, Matthew J. Pezone, James J. Collins

Figure 1. Physician rankings from 0 to 100 in the odds of prescribing an antibiotic. The y-axis represents the null ... Figure 1. Physician rankings from.

Volume 75, Issue 1, Pages (January 2009)

Figure 1. Mean concentration–time profiles of ascending doses of ivermectin in (a) PSAC and (b) SAC. Weight-dependent ... Figure 1. Mean concentration–time.

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*,

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Evaluation of the performance of the Helico Blot 2

Figure 1. Flow diagram for selection of articles for systematic review. Unless provided in the caption above, the following copyright applies to the content.

Supplemental Figure 6 Supplemental Figure 6. Treatment with erlotinib plus TAS-115 inhibits the growth of PC-9/HGF tumors in vivo. (A, B) Nude mice bearing.

Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity R.J.L.F. Loffeld, C.A.P.M.J.

Supplementary Figure 5: Effect of S48168 on normalized organ and skeletal muscle weights after 12 weeks of treatment for all the experimental groups from.

Eradication Therapy for Helicobacter pylori

Figure 1. Biofilm susceptibility to antibiotic treatment

Impact of medical data on bacterial diversity of fractionated samples.

Figure 2. Kaplan–Meier table showing the percentage of patients who were still symptomatic after 1 week of self-treatment (22 treatment sessions). Figure.

Enrollment, outcomes, and pharmacokinetics.

Efficacy of BP2 in treatment of biomaterial-associated S

Effects of broccoli sprouts (BS) or alfalfa sprouts (AS) on H

Presentation transcript:

From: Mastic gum has no effect on Helicobacter pylori load in vivo Figure 1. δ Urea breath test values for each of the eight completed volunteer patients before, immediately after and 5 weeks after 2 week treatment with mastic 1 g four times daily. H. pylori negative patients have δ UBT values of less than 3.5. Treatment with mastic had no effect on UBT values implying no significant effect on H. pylori load. In comparison, even single doses of antibiotics reduce bacterial load sufficiently to render urea breath tests temporarily negative. From: Mastic gum has no effect on Helicobacter pylori load in vivo J Antimicrob Chemother. 2003;52(3):522-523. doi:10.1093/jac/dkg366 J Antimicrob Chemother | 1